Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Grant of Options

November 21, 2019
Download  full announcement  Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces that the Remuneration Committee agreed to issue options over a total of 50,000 ordinary shares of £0.0025 each in the capital of the Company

Partnership with CDPHP on KidneyIntelX

October 17, 2019
Download  full announ c ement Effective October 16, KidneyIntelX will be covered for reimbursement for qualified members Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces that Capital District Physicians’ Health Plan,

Board appointment

October 14, 2019
Download  full  announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces the appointment of leading kidney investigator and clinician Dr. Chirag Parikh to the Renalytix board. Dr.

US CPT® reimbursement code effective

October 1, 2019
Download  full announ c ement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that CPT reimbursement code 0105U for its  KidneyIntelX™  test has become effective nationally in the United States as of October 1, 2019. 

Update on non-executive director appointment

September 30, 2019
Download  full announement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that it expects to appoint an additional non-executive director and healthcare industry veteran within the coming weeks.

Result of AGM

September 30, 2019
Download  full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces at its annual general meeting held earlier today, the following resolutions were passed on a show of hands with the table below summarising

Posting of Annual Report & Accounts and Notice of AGM

September 6, 2019
Download  full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical  in vitro  diagnostics for kidney disease, confirms that the Annual Report and Accounts for the period ended 30 June 2019  (“2019 Annual Report”), the Notice of the Annual General

Final results

September 3, 2019
Download  full announcement Renalytix AI plc (AIM: RENX), the AIM listed developer of artificial intelligence-enabled diagnostics for kidney disease, announces its inaugural final results for the period ended June 30, 2019. Operational highlights The U.S.
Displaying 151 - 160 of 203